- Home
- PATK vs NAMS Comparison
PATK vs NAMS Comparison
Compare PATK & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PATK
- NAMS
- Stock Information
- Founded
- PATK 1959
- NAMS 2019
- Country
- PATK United States
- NAMS Netherlands
- Employees
- PATK N/A
- NAMS N/A
- Industry
- PATK Auto Parts:O.E.M.
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- PATK Consumer Discretionary
- NAMS Health Care
- Exchange
- PATK Nasdaq
- NAMS Nasdaq
- Market Cap
- PATK 2.7B
- NAMS 2.5B
- IPO Year
- PATK N/A
- NAMS N/A
- Fundamental
- Price
- PATK $99.11
- NAMS $18.96
- Analyst Decision
- PATK Buy
- NAMS Strong Buy
- Analyst Count
- PATK 10
- NAMS 8
- Target Price
- PATK $101.63
- NAMS $42.88
- AVG Volume (30 Days)
- PATK 312.0K
- NAMS 1.0M
- Earning Date
- PATK 07-31-2025
- NAMS 08-06-2025
- Dividend Yield
- PATK 1.68%
- NAMS N/A
- EPS Growth
- PATK N/A
- NAMS N/A
- EPS
- PATK 4.16
- NAMS N/A
- Revenue
- PATK $3,785,611,000.00
- NAMS $47,140,000.00
- Revenue This Year
- PATK $3.48
- NAMS N/A
- Revenue Next Year
- PATK $5.90
- NAMS N/A
- P/E Ratio
- PATK $22.90
- NAMS N/A
- Revenue Growth
- PATK 8.12
- NAMS 586.97
- 52 Week Low
- PATK $69.86
- NAMS $14.06
- 52 Week High
- PATK $99.16
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- PATK 70.86
- NAMS 51.31
- Support Level
- PATK $90.79
- NAMS $17.97
- Resistance Level
- PATK $92.95
- NAMS $18.97
- Average True Range (ATR)
- PATK 3.32
- NAMS 1.12
- MACD
- PATK 0.57
- NAMS -0.09
- Stochastic Oscillator
- PATK 98.95
- NAMS 31.07
About PATK Patrick Industries Inc.
Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.